BIOMAT Database Logo BIOMAT Database Logo

DNA amplification for detection of the XV-2c polymorphism linked to cystic fibrosis. 1989

C L Rosenbloom, and B S Kerem, and J M Rommens, and L C Tsui, and B Wainwright, and R Williamson, and W E O'Brien, and A L Beaudet
Howard Hughes Medical Institute, Baylor College of Medicine, Houston, TX 77030.

UI MeSH Term Description Entries
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D002897 Chromosomes, Human, Pair 7 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 7
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D005784 Gene Amplification A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication. Amplification, Gene
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015252 Deoxyribonucleases, Type II Site-Specific Enzyme systems containing a single subunit and requiring only magnesium for endonucleolytic activity. The corresponding modification methylases are separate enzymes. The systems recognize specific short DNA sequences and cleave either within, or at a short specific distance from, the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.4. DNA Restriction Enzymes, Type II,DNase, Site-Specific, Type II,Restriction Endonucleases, Type II,Type II Restriction Enzymes,DNase, Site Specific, Type II,Deoxyribonucleases, Type II, Site Specific,Deoxyribonucleases, Type II, Site-Specific,Site-Specific DNase, Type II,Type II Site Specific DNase,Type II Site Specific Deoxyribonucleases,Type II Site-Specific DNase,Type II Site-Specific Deoxyribonucleases,Deoxyribonucleases, Type II Site Specific,Site Specific DNase, Type II
D015345 Oligonucleotide Probes Synthetic or natural oligonucleotides used in hybridization studies in order to identify and study specific nucleic acid fragments, e.g., DNA segments near or within a specific gene locus or gene. The probe hybridizes with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, Southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the probe include the radioisotope labels 32P and 125I and the chemical label biotin. Oligodeoxyribonucleotide Probes,Oligonucleotide Probe,Oligoribonucleotide Probes,Probe, Oligonucleotide,Probes, Oligodeoxyribonucleotide,Probes, Oligonucleotide,Probes, Oligoribonucleotide

Related Publications

C L Rosenbloom, and B S Kerem, and J M Rommens, and L C Tsui, and B Wainwright, and R Williamson, and W E O'Brien, and A L Beaudet
Additional polymorphism for D7S8 linked to cystic fibrosis including detection by DNA amplification.
February 1989, Nucleic acids research,
C L Rosenbloom, and B S Kerem, and J M Rommens, and L C Tsui, and B Wainwright, and R Williamson, and W E O'Brien, and A L Beaudet
Amplification of DNA for detection of cystic fibrosis-linked polymorphisms.
November 1989, The Journal of pediatrics,
C L Rosenbloom, and B S Kerem, and J M Rommens, and L C Tsui, and B Wainwright, and R Williamson, and W E O'Brien, and A L Beaudet
Prenatal diagnosis of cystic fibrosis by DNA amplification for detection of KM-19 polymorphism.
July 1988, Lancet (London, England),
C L Rosenbloom, and B S Kerem, and J M Rommens, and L C Tsui, and B Wainwright, and R Williamson, and W E O'Brien, and A L Beaudet
Linkage disequilibrium between cystic fibrosis and linked DNA polymorphisms at two DNA markers, XV-2c and KM. 19, in North African families.
October 1989, American journal of human genetics,
C L Rosenbloom, and B S Kerem, and J M Rommens, and L C Tsui, and B Wainwright, and R Williamson, and W E O'Brien, and A L Beaudet
[DNA amplification in the study of polymorphisms linked to the cystic fibrosis gene].
September 1989, Journal de genetique humaine,
C L Rosenbloom, and B S Kerem, and J M Rommens, and L C Tsui, and B Wainwright, and R Williamson, and W E O'Brien, and A L Beaudet
XV-2c/KM19 haplotypes analysis of cystic fibrosis patients from western Mexico.
September 2008, Acta physiologica Hungarica,
C L Rosenbloom, and B S Kerem, and J M Rommens, and L C Tsui, and B Wainwright, and R Williamson, and W E O'Brien, and A L Beaudet
XV-2c/KM-19 haplotype analysis of cystic fibrosis mutations in Mexican patients.
August 2001, American journal of medical genetics,
C L Rosenbloom, and B S Kerem, and J M Rommens, and L C Tsui, and B Wainwright, and R Williamson, and W E O'Brien, and A L Beaudet
Cystic fibrosis in the Brazilian population: DF508 mutation and KM-19/XV-2C haplotype distribution.
August 1997, Human biology,
C L Rosenbloom, and B S Kerem, and J M Rommens, and L C Tsui, and B Wainwright, and R Williamson, and W E O'Brien, and A L Beaudet
Linkage disequilibrium between cystic fibrosis locus and three DNA markers, XV-2c, KM19 and MP6d-9, in 43 Spanish families.
March 1990, Human genetics,
C L Rosenbloom, and B S Kerem, and J M Rommens, and L C Tsui, and B Wainwright, and R Williamson, and W E O'Brien, and A L Beaudet
Dinucleotide repeat polymorphism closely linked to the cystic fibrosis (CFTR) gene.
October 1991, Nucleic acids research,
Copied contents to your clipboard!